Eledon pharmaceuticals to present at the virtual ladenburg thalmann healthcare conference

Irvine, calif., june 29, 2021 (globe newswire) -- eledon pharmaceuticals, inc. (“eledon”) (nasdaq: eldn), a clinical stage biopharmaceutical company focused on developing targeted medicines for persons living with autoimmune disease, requiring an organ or cell-based transplant, or living with amyotrophic lateral sclerosis (als), today announced that management will present a corporate overview at the virtual ladenburg thalmann healthcare conference on tuesday, july 13 th at 2:00 pm est.
ELDN Ratings Summary
ELDN Quant Ranking